drug development
Danaher Launches US, UK Laboratories for Precision Medicine Test Development
The CLIA- and CAP-certified laboratories are intended to accelerate the development of companion diagnostics and complementary diagnostics.
Adaptive Biotechnologies, BeiGene Partner for Lymphoid Malignancy Drug Development
Adaptive’s ClonoSeq assay will be used to assess MRD across BeiGene’s pipeline of treatments for patients with lymphoid malignancies.
Foundation Medicine, Bristol Myers Squibb Expand CDx Partnership to Investigational Cancer Drug
The companies are working to establish FoundationOne CDx as a companion diagnostic for BMS's investigational tyrosine kinase inhibitor repotrectinib.
Guardant Health Licenses Genomic Cancer Assays to Adicon for Testing in China
Under the agreement, Adicon will provide biopharmaceutical companies conducting clinical trials in China access to Guardant's tissue and liquid biopsy tests.
Roche, Bristol Myers Squibb Partner on Digital Pathology Algorithms, Assays for Cancer Diagnosis
Under the collaboration, Roche is developing an artificial intelligence-based image analysis algorithm to help pathologists interpret its Ventana PD-L1 (SP142) Assay.